European Surveillance of Antimicrobial Consumption (ESAC): Quality indicators for outpatient antibiotic use in Europe

Quality and Safety in Health Care

Volumn 16, Issue 6, 2007, Pages 440-445

  Coenen, Samuel ^a   Ferech, Matus ^a   Haaijer Ruskamp, Flora M ^b   Butler, Chris C ^c   Vander Stichele, Robert H ^d   Verheij, Theo J M ^e   Monnet, Dominique L ^f   Little, Paul ^g   Goossens, Herman ^a   Mittermayer, Helmut ^h   Metz, Sigrid ^h   Markova, Boyka ^h   Francetic, Igor ^h   Bagatzouni, Despo ^h   Nielsen, Annemette Anker ^h   Rootslane, Ly ^h   Huovinen, Pentti ^h   Paakkari, Pirkko ^h   Guillemot, Didier ^h   Kern, Winfried ^h   Schroeder, Helmut ^h   Giamarellou, Helen ^h   Antoniadou, Anastasia ^h   Ternak, Gabor ^h   Benko, Ria ^h   Kristinsson, Karl ^h   Cunney, Robert ^h   Oza, Ajay ^h   Raz, Raul ^h   Cornaglia, Giuseppe ^h   Hemmer, Robert ^h   Bruch, Marcel ^h   Borg, Michael ^h   Zarb, Peter ^h   Filius, Margreet ^h   Hryniewicz, Waleria ^h   Caldeira, Luis ^h   Codita, Irma ^h   Ratchina, Svetlana ^h   Foltan, Viliam ^h   Tesar, Tomas ^h   Lazaro, Edurne ^h   De Abajo, Francisco ^h   Cars, Otto ^h   Skoog, Gunilla ^h   Masiero, Giuliano ^h   Unal, Serhat ^h   more..

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f STATENS SERUM INSTITUT   (Denmark)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h Community Clinical Sciences ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; EUROPE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT CARE; PATIENT SAFETY; PRESCRIPTION; PRIMARY MEDICAL CARE; QUALITY CONTROL; WORLD HEALTH ORGANIZATION;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BENCHMARKING; COST-BENEFIT ANALYSIS; DIAGNOSIS-RELATED GROUPS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; EUROPE; GUIDELINES AS TOPIC; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; POLICY MAKING; POPULATION SURVEILLANCE; PUBLIC HEALTH; QUALITY INDICATORS, HEALTH CARE;

EID: 37749011672     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2006.021121     Document Type: Article

References (30)

1. Powell AE, Davies HTO, Thomson RG. Using routine comparative data to assess the quality of health care: understanding and avoiding common pitfalls. Qual Saf Health Care 2003;12:122-8.
2. Seddon ME, Marshall MN, Campbell SM, et al. Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand. Qual Health Care 2001;10:152-8.
3. Pont L, Denig P, van der Molen T, et al. Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol 2004;59:833-40.
4. Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000;321:425-8.
5. The EURO-MED-STAT Group. Monitoring expenditure and utilisation of medicines in the European Union. A public health approach. Ital J Pub Health 2006;3:15-21.
6. Bronzwaer S, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278-82.
7. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
8. Malhotra-Kumar S, Lammens C, Coenen S, et al. Impact of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007;369:482-90.
9. Bruinsma N, Kristinsson KG, Bronzwaer S, et al. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother 2004;54:1045-50.
10. Goossens H, Sprenger MJW. Community acquired infections and bacterial resistance. BMJ 1998;317:054-7.
11. Anon. Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities L34. 2002;45:13-6.
12. Vander Stichele R, Elseviers M, Ferech M, et al. European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 2004;58:419-28.
13. Ferech M, Coenen S, Malhotra-Kumar S, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006;58:401-7.
14. Ferech M, Coenen S, Dvorakova K, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J Antimicrob Chemother 2006;58:408-12.
15. Coenen S, Ferech M, Dvorakova K, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe. J Antimicrob Chemother 2006;58:413-7.
16. Coenen S, Ferech M, Malhotra-Kumar S, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006;58:418-22.
17. Ferech M, Coenen S, Malhotra-Kumar S, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother 2006;58:423-7.
18. Hoven J, Haaijer-Ruskamp F, Vander Stichele R. Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). Eur J Clin Pharmacol 2005;60:831-34.
19. Ontwikkeling van indicatoren op basis van evidence-based richtlijnen [Development of indicators based on evidence-based guidelines]: Kwaliteitsinstituut voor de gezondheidszorg CBO, 2002.
20. Campbell S, Braspenning J, Hutchinson A, et al. Improving the quality of health care: Research methods used in developing and applying quality indicators in primary care. BMJ 2003;326:816-9.
21. Holden J, Wilson R. The quality of prescribing in general practice. Int J Health Care Qual Assur 1996;9:17-23.
22. Avery A. Appropriate prescribing in general practice: development of the indicators. Qual Saf Health Care 1998;7:123.
23. Coenen S, Ferech M, Goossens H. EMRC ESF explorative workshop on antibiotic prescribing quality indicators. Scientific report. Antwerp, University of Antwerp, 2005, 9 November 2006; Search via http://www.esf.org (accessed 6 March 2007).
24. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA appropriateness method user's manual, Santa Monica, CA: RAND Corporation, 2001; http://www.rand.org/pubs/monograph_reports/MR1269/index.html (accessed 6 March 2007).
25. Shekelle P, Kahan J, Bernstein S, et al. The reproducibility of a method to identify the overuse and underuse of procedures. N Engl J Med 1998;338:1888-95.
26. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification system: Guidelines for ATC classification and DDD assignment. Oslo: Norwegian Institute of Public Health, 2006; http://www.whocc.no/atcddd/ (accessed 6 March 2007).
27. World Health Organization Regional Office for Europe. European health for all database, 2006.http://www.euro.who.int/hfadb (accessed 6 March 2007).
28. Akkerman AE, Kuyvenhoven MM, van der Wouden JC, et al. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother 2005;56:930-6.
29. van den Berg M, de Bakker D, van Roosmalen M, et al. De staat van de huisartsenzorg [The state of the general practice care] [In Dutch]. Utrecht: NIVEL, 2005, htrp://www.nivel.nl/pdf/De-staat-van-huisartsenzorg-2005. pdf (accessed 6 March 2007).
30. Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006;62:373-9.